DrugPatentWatch Database Preview
CHILDREN'S ZYRTEC ALLERGY Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Children's Zyrtec Allergy, and what generic alternatives are available?
Children's Zyrtec Allergy is a drug marketed by J And J Consumer Inc and is included in two NDAs.
The generic ingredient in CHILDREN'S ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and forty suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Children's Zyrtec Allergy
A generic version of CHILDREN'S ZYRTEC ALLERGY was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.
Summary for CHILDREN'S ZYRTEC ALLERGY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 94 |
| Clinical Trials: | 4 |
| Patent Applications: | 1,867 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CHILDREN'S ZYRTEC ALLERGY at DailyMed |
Recent Clinical Trials for CHILDREN'S ZYRTEC ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Merck Sharp & Dohme Corp. | Phase 4 |
| Merck Sharp & Dohme Corp. | Phase 3 |
| Pfizer | Phase 4 |
Synonyms for CHILDREN'S ZYRTEC ALLERGY
| (+-)-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid, dihydrochloride |
| (+) {2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazine-1-yl] -ethoxy}-acetic acid dihydrochloride |
| (+/-)-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]acetic acid, dihydrochloride |
| (+/-){2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]-ethoxy}-acetic acid dihydrochloride |
| (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid dihydrochloride |
| (2-{4-[(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid--hydrogen chloride (1/2) |
| (R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride |
| (RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy }-acetic acid dihydrochloride |
| (RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy}-acetic acid dihydrochloride |
| [2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]aceticaciddihydrochloride |
| 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrichloride |
| 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride |
| 83881-52-1 |
| 881C510 |
| A840675 |
| AB0008484 |
| AB1009381 |
| AC-1600 |
| AC-170 |
| Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride |
| Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)- |
| AK108356 |
| AK176131 |
| AKOS000280979 |
| AKOS016340521 |
| Alercet |
| Alergex |
| Alerid |
| Alerlisin |
| Alertisin |
| Allergy relief |
| Alleroff |
| ANW-69482 |
| API0001938 |
| Apo-Cetirizine |
| AX8022801 |
| BCP09018 |
| BG0436 |
| C21H25ClN2O3.2HCl |
| C21H27Cl3N2O3 |
| CAS-83881-52-1 |
| CC0256 |
| CCG-213404 |
| Cetalerg |
| Ceterifug |
| Ceti TAD |
| Ceti-Puren |
| Cetiderm |
| Cetidura |
| Cetil von ct |
| CetiLich |
| Cetirigamma |
| Cetirizin AZU |
| Cetirizin Basics |
| Cetirizin dihydrochloride, >=98.0% (HPLC) |
| Cetirizine (dihydrochloride) |
| Cetirizine 2HCl |
| Cetirizine Di |
| Cetirizine diHCl |
| Cetirizine dihydrochloride |
| Cetirizine Dihydrochloride 1.0 mg/ml in Water (as free base) |
| Cetirizine dihydrochloride solution, 1.0 mg/mL in acetonitrile: water (9:1) (as free base), ampule of 1 mL, certified reference material |
| Cetirizine dihydrochloride, >=98% (HPLC) |
| Cetirizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Cetirizine dihydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Cetirizine for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Cetirizine HCl |
| CETIRIZINE HYDROCHLORIDE |
| Cetirizine hydrochloride (JP17/USAN) |
| Cetirizine hydrochloride [USAN:USP] |
| Cetirizine hydrochloride [USAN] |
| Cetirizine Hydrochloride Allergy |
| Cetirizine Hydrochloride Hives |
| Cetirizine hydrochloride, British Pharmacopoeia (BP) Reference Standard |
| Cetirizine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
| cetirizine-dihydrochloride |
| cetirizinedihydrochloride |
| Cetirlan |
| Cetriler |
| Cetrine |
| Cetzine |
| Cezin |
| CHEBI:3562 |
| CHEMBL1607273 |
| Children's Cetirizine hydrochloride allergy |
| Children's Cetirizine hydrochloride hives relief |
| Children's Zyrtec |
| Children's Zyrtec Hives Relief |
| CS-1798 |
| CTK8C2999 |
| D00664 |
| DB-056756 |
| DSSTox_CID_24268 |
| DSSTox_GSID_44268 |
| DSSTox_RID_80138 |
| DTXSID2044268 |
| Formistin |
| FT-0603000 |
| HMS1569F07 |
| HMS1922H04 |
| HY-17042A |
| J10151 |
| KS-000015AD |
| KS-1042 |
| LP00362 |
| LS-11411 |
| NCGC00016949-01 |
| NCGC00095180-01 |
| NCGC00095180-02 |
| NCGC00255965-01 |
| NCGC00261047-01 |
| NCGC00263567-01 |
| OX-NLA |
| P 071 |
| P-071 |
| PGLIUCLTXOYQMV-UHFFFAOYSA-N |
| Prestwick_841 |
| Q27263769 |
| Reactine |
| Ressital |
| Riztec |
| RTR-026026 |
| Ryzen |
| s1291 |
| Salvalerg |
| SCHEMBL41107 |
| Setiral |
| SPECTRUM1505371 |
| SR-01000688282 |
| SR-01000688282-3 |
| ST077146 |
| ST24039138 |
| Stopaler |
| Sun mark all day allergy |
| SW196972-3 |
| Topcare all day allergy |
| Tox21_110704 |
| Tox21_110704_1 |
| Tox21_302261 |
| Tox21_500362 |
| Triz |
| UCB P071 |
| UCB-P 071 |
| Up and up all day allergy relief |
| Virdos |
| Voltric |
| Xero-sed |
| Zerviate |
| Zetir |
| Zirtin |
| Zyrtec |
| Zyrtec (TN) |
| Zyrtec Allergy |
| Zyrtec Hives Relief |
| Zyrzine |
Paragraph IV (Patent) Challenges for CHILDREN'S ZYRTEC ALLERGY
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| CHILDREN'S ZYRTEC ALLERGY | TABLET, CHEWABLE;ORAL | cetirizine hydrochloride | 021621 | 2005-03-25 |
| CHILDREN'S ZYRTEC HIVES RELIEF | TABLET, CHEWABLE;ORAL | cetirizine hydrochloride | 021621 | 2005-03-25 |
US Patents and Regulatory Information for CHILDREN'S ZYRTEC ALLERGY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | SYRUP;ORAL | 022155-002 | Nov 16, 2007 | OTC | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, CHEWABLE;ORAL | 021621-003 | Nov 16, 2007 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, CHEWABLE;ORAL | 021621-004 | Nov 16, 2007 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHILDREN'S ZYRTEC ALLERGY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, CHEWABLE;ORAL | 021621-003 | Nov 16, 2007 | Start Trial | Start Trial |
| J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, CHEWABLE;ORAL | 021621-004 | Nov 16, 2007 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CHILDREN'S ZYRTEC ALLERGY
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Yugoslavia | 23782 | Start Trial |
| Bosnia and Herzegovina | 97199 | Start Trial |
| Austria | 224717 | Start Trial |
| South Korea | 20010014398 | Start Trial |
| Japan | 2002508773 | Start Trial |
| Poland | 234935 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CHILDREN'S ZYRTEC ALLERGY
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0058146 | 2001C/045 | Belgium | Start Trial | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| 0058146 | SPC/GB01/052 | United Kingdom | Start Trial | SPC/GB01/052:, EXPIRES: 20070205 |
| 0663828 | C300085 | Netherlands | Start Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
